Product Information
DEXAMETHASONE 4 MG/ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.6735 per ML under NDC 63323016516. Its NADAC has been published 268 times since Jan 23, 2019.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
4 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323016516
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
DEXAMETHASONE SODIUM PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA084916FDA Approved
Before 1982
TE Code
AP
On Market Since
9/7/2000
Pharmacological Classes
Price Statistics
The NADAC for DEXAMETHASONE 4 MG/ML VIAL has been published 268 times since Jan 23, 2019, and over the history we have for it it has declined 14.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6735 per ML |
|---|---|
| All-time high | $1.3879 (Sep 15, 2021) |
| All-time low | $0.5860 (Apr 22, 2020) |
| 52-week high | $0.8198 |
| 52-week low | $0.6575 |
| Median price | $0.7748 |
| Average price | $0.8589 |
| Largest weekly change | +136.8% (Sep 23, 2020) |
| Weeks tracked | 268 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 73% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DEXAMETHASONE SODIUM PHOSPHATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXAMETHASONE 4 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DEXAMETHASONE 4 MG/ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.6735 per ML (NDC 63323016516), effective Sep 30, 2026.
How has the price of DEXAMETHASONE 4 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for DEXAMETHASONE 4 MG/ML VIAL has declined 14.5%. It has been tracked across 268 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for DEXAMETHASONE 4 MG/ML VIAL?
Since Jan 23, 2019, the NADAC for DEXAMETHASONE 4 MG/ML VIAL has ranged from a low of $0.5860 (Apr 22, 2020) to a high of $1.3879 (Sep 15, 2021), with a median of $0.7748 per ML.
Are there cheaper alternatives to DEXAMETHASONE 4 MG/ML VIAL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXAMETHASONE 20 MG/5 ML VIAL, is $0.1807 per ML — about 73% below DEXAMETHASONE 4 MG/ML VIAL.
Who manufactures DEXAMETHASONE 4 MG/ML VIAL?
DEXAMETHASONE 4 MG/ML VIAL (NDC 63323016516) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.